Reman Lifecare Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 02-01-2025
- Paid Up Capital ₹ 1.20 M
as on 02-01-2025
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 14.17%
(FY 2022)
- Profit 111.64%
(FY 2022)
- Ebitda 1901.71%
(FY 2022)
- Net Worth 125.42%
(FY 2022)
- Total Assets -14.24%
(FY 2022)
About Reman Lifecare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.20 M, as per Ministry of Corporate Affairs (MCA) records.
Aslam Rizvi, Ahmer Rizvi, and Arshad Rizvi serve as directors at the Company.
- CIN/LLPIN
U51909BR2017PTC035988
- Company No.
035988
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Oct 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Reman Lifecare Private Limited offer?
Reman Lifecare Private Limited offers a wide range of products and services, including Child and Baby Care Products, Baby Oil, Pharma & Bioanalytical Services, PCD Pharma Franchise, Nutraceuticals & Dietary Supplements, Mineral Supplement, Nutritional Supplements, Pharmaceutical Third Party Manufacturing, Ayurvedic,Herbal Products & Medicine, Ayurvedic Herbal Syrups & Tonics.
Who are the key members and board of directors at Reman Lifecare?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ahmer Rizvi  | Managing Director | 11-Oct-2017 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aslam Rizvi | Director | 11-Oct-2017 | Current |
| Arshad Rizvi | Additional Director | 20-Jan-2018 | Current |
Financial Performance of Reman Lifecare.
Reman Lifecare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 14.17% increase. The company also saw a substantial improvement in profitability, with a 111.64% increase in profit. The company's net worth Soared by an impressive increase of 125.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Reman Lifecare?
In 2021, Reman Lifecare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Reman Lifecare?
Unlock and access historical data on people associated with Reman Lifecare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Reman Lifecare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reman Lifecare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.